The association analyses were performed at both SNP and haplotype levels. We further verified our findings in an independent cohort of 442 ischemic stroke cases and 502 control subjects. In the first study, rs2383206, rs1004638, and rs10757278 in block 3 were significantly associated with CAD but not with ischemic stroke independent of traditional cardiovascular
risk factors in additive model (P = 0.002 to 0.0001, q = 0.026 to 0.004). Analysis from all blocks revealed that haplotype profiles of block 3 on 9p21 were significantly different between shared control and cases of CAD (P = 1.3 x 10(-10), q = 1.2 x 10(-9)) and ischemic stroke (P = 1.7 x 10(-6), q = 7.7 x 10(-6)). In the expanded second case-control study, block 3 on 9p21 remained associated with ischemic stroke (P = 2.6 x SBE-β-CD nmr 10(-4), q = 6.3 x 10(-4)).
Conclusions-Our results suggest for the CA4P cost first time that 9p21 is a shared susceptibility locus, strongly
for CAD and weakly for ischemic stroke, in a Chinese Han population. (Circ Cardiovasc Genet. 2009; 2: 338-346.)”
“Background-A common variant at chromosome 9p21 (tagged by the rs1333049 or rs10757278 single-nucleotide polymorphism) is strongly associated with myocardial infarction and major arterial aneurysms. An association with peripheral arterial disease (PAD) was also reported in a sample younger than 75 years, but this disappeared on removal of respondents with a myocardial infarction history, resulting in an odds ratio of 1.09 for PAD (P = 0.075). We aimed at estimating the association of this variant with an Ankle-Brachial Index (ABI) and PAD in 3 older populations.
Methods and Results-We used data from the InCHIANTI, Baltimore Longitudinal Study of Aging, and Health, Aging, and Body Composition studies. In 2630 white individuals
(mean age, 76.4 years), selleck inhibitor the C allele at rs1333049 was associated with lower mean ABI measures and with an increased prevalence of PAD. These associations remained after removal of baseline and incident myocardial infarction cases over a 6-year follow-up for both ABI (-0.017 ABI units; 95% CI, -0.03 to -0.01; P = 1.3 x 10(-4)) and PAD (per allele odds ratio, 1.29; 95% CI, 1.06 to 1.56; P = 0.012). These associations also remained after adjustment for known atherosclerosis risk factors, including diabetes mellitus, smoking, hypercholesterolemia, and hypertension.
Conclusions-The C allele at rs1333049 is associated with an increased prevalence of PAD and lower mean ABI. This association was independent of the presence of diagnosed myocardial infarction and atherosclerotic risk factors in 3 older white populations. (Circ Cardiovasc Genet. 2009; 2: 347-353.